SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT03950271 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03950271
- Sponsor
- Henan Cancer Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-20
- Primary completion
- 2024-01-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.